Embody vs IVIM Health: Cost, Protocol, and Delivery Compared
Quick verdict: Embody is the lowest-cost, no-frills option for compounded semaglutide with $69/month pricing and free 1–2 day shipping after approval, while IVIM Health focuses on clinician-guided protocols, third-party ratings, and program features with a different fee structure.
See Embody pricing and shipping details
Embody vs IVIM Health: how they differ at a glance
This comparison uses only supplied facts. Both platforms prescribe compounded GLP-1 medications after clinician review, but they differ most clearly on price, program structure and fees, delivery speed and commitments, and third-party validation or protocol claims. The rest of this article contrasts those differences directly.
1. Price and billing model
Embody lists compounded semaglutide at $69/month and compounded tirzepatide at $119/month. The $69 semaglutide price is presented as a reduced price from $299 and described as a limited-time offer that may increase. Embody emphasizes flat locked-in monthly pricing, no monthly membership, and no insurance required.
IVIM Health lists semaglutide at $75/month on landing-page evidence and describes an offer structure that includes a first-month rate and ongoing fees. IVIM’s materials note a $99 first month and $174/month ongoing in some FAQ language, plus a program fee of $74.99/month in other captured details. IVIM also advertises a free month membership with code GIFT75 and a no-obligation free consultation valued at $75 for new patients. IVIM’s ongoing pricing is presented as a clinician-guided program with program fees.
View IVIM Health enrollment and the GIFT75 offer
2. Program structure and clinical protocol
Embody positions itself as a prescription-forward, no-frills telehealth platform: prescription and telemed visits are included, with licensed provider review handled online. Embody highlights 24/7 support access for dosing and side-effect questions but says it has fewer premium features such as integrated coaching or advanced monitoring.
IVIM Health emphasizes a clinician-guided GLP-1 ID protocol that it says can accelerate weight loss outcomes. IVIM describes its GLP-1 ID protocol as proprietary and claims that patients following the protocol lost an average of 46% more weight over 68 weeks compared to another published clinical GLP-1 trial; the source notes this is not a head-to-head study. The 40% faster claim is described as IVIM’s proprietary protocol claim and not an independent clinical finding.
3. Third-party validation and satisfaction signals
Embody’s evidence emphasizes low price and fast shipping but does not supply third-party rating claims in the supplied row. IVIM Health supplies a notable third-party signal: a 4.9-star rating on both Google and Trustpilot, described as rare dual third-party verification and a compelling trust signal for patients who prioritize external reviews.
4. Shipping speed, commitments, and cancellation
Embody: free shipping, arrives in 1 to 2 days after clinician approval, no monthly membership, cancel anytime. The landing page evidence repeats fast 1 to 2 day delivery and no long-term commitment required.
IVIM: captured materials do not advertise a specific shipping speed in the supplied row but do note that compounded medications are prepared by licensed compounding pharmacies and that medications are prescribed only after consultation. IVIM materials also state not available in all states. Both providers note that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Comparison table: Embody vs IVIM Health
| Criteria | Embody | IVIM Health |
|---|---|---|
| Semaglutide starting price | $69/month (compounded; was $299) | $75/mo listed; FAQ notes $99 first month, $174/month ongoing |
| Tirzepatide price | $119/month (compounded) | $133/month listed |
| Membership / program fees | No monthly membership; cancel anytime | Program fee captured at +$74.99/mo; free month with code GIFT75 |
| Shipping / delivery | Free shipping; arrives in 1 to 2 days after approval | Medications from compounding pharmacies; shipping speed not specified in captured row |
| Protocol & coaching | No integrated coaching or advanced monitoring noted | Proprietary GLP-1 ID protocol; clinician-guided titration claimed |
| Third-party reviews | Not supplied in captured row | 4.9 stars on Google and Trustpilot (captured claim) |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
Safety and regulatory language
Both providers’ captured materials explicitly state that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. IVIM additionally notes that results may vary and that some outcome claims are based on internal or published observational studies rather than randomized head-to-head trials.
Get Embody semaglutide details and clinician review
Which differences matter most
If your primary priority is lowest entry price and fastest advertised shipping after approval, Embody is supported by the supplied facts as the cost-driven choice with $69/month semaglutide, flat pricing, and 1 to 2 day free delivery. If you prioritize third-party validation, a proprietary clinician protocol, and a structured program even if fees and ongoing costs are higher, IVIM Health is presented in the supplied evidence as the choice with strong external ratings and a GLP-1 ID protocol.
Start with Embody pricing and shipping
Conclusion: Embody vs IVIM Health
Embody vs IVIM Health comes down to trade-offs shown in the supplied facts: Embody offers the lowest advertised semaglutide price at $69/month, free 1 to 2 day shipping after approval, and a no-membership model. IVIM Health emphasizes clinician-guided optimization through its GLP-1 ID protocol, strong third-party ratings, and membership or program fee structures including promotional options such as code GIFT75 and a free consultation valued at $75.
Choose Embody if you want the lowest entry price and fast stated shipping with a no-membership, prescription-forward approach. Choose IVIM Health if you value dual 4.9-star third-party ratings and a proprietary clinician-guided protocol and are prepared for membership or program fees as described in IVIM’s materials.